Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage

DNA damage response and repair in the development and treatment of brain tumors

(2022) Parisa Maleki Dana et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Dual‐Loaded Liposomes Tagged with Hyaluronic Acid Have Synergistic Effects in Triple‐Negative Breast Cancer

(2022) Shiyan Dong et al.   Small

GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway

(2022) Jianrong Na et al.   TISSUE & CELL

Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis

(2022) Bin Jia et al.   Thoracic Cancer

Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer ( NSCLC ) through apoptosis

(2022) Changchun Zhu et al.   Thoracic Cancer

Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma

(2022) Yi Chen et al.   Frontiers in Pharmacology

VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo

(2022) Jiacheng Wu et al.   Frontiers in Pharmacology

The human VRK1 chromatin kinase in cancer biology

(2021) Ignacio Campillo-Marcos et al.   CANCER LETTERS

DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells

(2021) Rebeca Carrión-Marchante et al.   Pharmaceuticals

HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating VRK1 Translation

(2021) Hye Guk Ryu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Circular RNA VRK1 correlates with favourable prognosis, inhibits cell proliferation but promotes apoptosis in breast cancer

(2020) Yang Li et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy

(2020) Josephine Hai et al.   CLINICAL CANCER RESEARCH

Metal ions modify DNA-protecting and mutagen-scavenging capacities of the AV-153 1,4-dihydropyridine

(2019) Elina Leonova et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

(2019) Narjust Duma et al.   MAYO CLINIC PROCEEDINGS

High expression of VRK1 is related to poor prognosis in glioma

(2018) Zhiyun Ben et al.   PATHOLOGY RESEARCH AND PRACTICE

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells

(2018) Aye M. Mon et al.   PLoS One

VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma

(2017) Zhen-Chuan Liu et al.   Oncotarget

Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations

(2017) Rafael M. Couñago et al.   Scientific Reports

Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma

(2016) Jing Liu et al.   Hematology

Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities

(2012) P. Perez-Moreno et al.   CLINICAL CANCER RESEARCH

Doxorubicin: The Good, the Bad and the Ugly Effect

(2009) Cristina Carvalho et al.   CURRENT MEDICINAL CHEMISTRY

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

(2009) Robert Pirker et al.   LANCET